Well, it is July 15th, middle of the month and we
Post# of 36537
(Total Views: 322)
Posted On: 07/15/2021 12:33:36 PM
Well, it is July 15th, middle of the month and we are still waiting on the IND and basically anything from Generex / NGIO. Anything.
This is a company that has products, that has the science. I have always stated they have everything there in products and science. What they don't have is the communication and I still can't wrap my head around that part.
In a world where communication is key to everything, the management seems lacking in almost every aspect of it. You can have the greatest products in the world, but if you have terrible communication and the other guys have mediocre products, but great communication, they are going to beat you almost every time. We are seeing here bad results with mRNA vaccines in many areas, but the communication from all areas is being pushed. We are seeing from Generex / NGIO - nothing. Absolutely nothing.
Yes, they haven't put in the IND yet, but where is it? Why are they not talking about what is going on right now and what their 'complete vaccine' can and will do for people? If not in a PR, then on their web site, etc.. Promoting it all the time.
What about the other products? They are not just a Covid vaccine company. They are a multi product company and yet, nothing.
The lack of communication is simply staggering. And it is showing in the PPS, in the volume, in the shareholder confidence, in new investors.
NGIO was supposed to be listed how many times as well? What happened to the 50 million? Where is the investment money that was supposed to have happened? No communication on that in how many months now.
All we have had is silence. In this scenario, silence is not golden.
This is a company that has products, that has the science. I have always stated they have everything there in products and science. What they don't have is the communication and I still can't wrap my head around that part.
In a world where communication is key to everything, the management seems lacking in almost every aspect of it. You can have the greatest products in the world, but if you have terrible communication and the other guys have mediocre products, but great communication, they are going to beat you almost every time. We are seeing here bad results with mRNA vaccines in many areas, but the communication from all areas is being pushed. We are seeing from Generex / NGIO - nothing. Absolutely nothing.
Yes, they haven't put in the IND yet, but where is it? Why are they not talking about what is going on right now and what their 'complete vaccine' can and will do for people? If not in a PR, then on their web site, etc.. Promoting it all the time.
What about the other products? They are not just a Covid vaccine company. They are a multi product company and yet, nothing.
The lack of communication is simply staggering. And it is showing in the PPS, in the volume, in the shareholder confidence, in new investors.
NGIO was supposed to be listed how many times as well? What happened to the 50 million? Where is the investment money that was supposed to have happened? No communication on that in how many months now.
All we have had is silence. In this scenario, silence is not golden.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼